Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome. (Q40591654)
Jump to navigation
Jump to search
scientific article published on December 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome. |
scientific article published on December 2001 |
Statements
Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome (English)
S T Lee
J H Jang
J S Hahn
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference